Re-analysis of our previously published mass-spectrometry-based proteomic profiling of CSF from patients with melanoma LMD shows SERPINA3 to be enriched in patients with LMD compared with no LMD controls (1.21 Log2 ratio, p < 0.001).5 This evidence concerns the gene SERPINA3 and Langer mesomelic dysplasia.